Sarcoma  >>  cyclophosphamide  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclophosphamide / Generic mfg.
2021-000125-27: TOLERANCE: a clinical trial on more tolerable treatments for elderly patients with advanced soft tissue sarcoma TOLERANCE: uno studio clinico su trattamenti piĆ¹ tollerabili per pazienti anziani con sarcoma dei tessuti molli avanzato

Ongoing
3
185
Europe, RoW
Doxorubicin, Cyclophosphamide, Prednisolone, [Doxorubicin], [Cyclophosphamide], [Prednisolone], Solution for injection/infusion, Coated tablet, Tablet
EORTC AISBL/IVZW, European Organisation for Research and Treatment of Cancer (EORTC), European Organisation for Research and Treatment of Cancer (EORTC), Fonds Cancer (FOCA), Rising Tide Foundation
Advanced/metastatic soft tissue sarcoma Sarcoma avanzato/metastatico dei tessuti molli, Sarcoma Sarcoma, Diseases [C] - Cancer [C04]
 
 
2014-000259-99: A comparison of four widely used chemotherapy regimens for the treatment of Ewing sarcoma, a type of bone cancer, to see which is most effective and/or has the fewest side effects.

Ongoing
2/3
400
Europe
Cyclophosphamide, Topotecan, Irinotecan, Temozolomide, Gemcitabine, Docetaxel, Ifosfamide, Cyclophosphamide, Topotecan, Irinotecan, Temozolomide, Gemcitabine, Docetaxel, Ifosfamide, Infusion, Capsule, hard, , Cyclophosphamide, HYCAMTIN, CAMPTO, Temodal, GEMZAR, TAXOTERE, Ifosfamide
University of Birmingham, UNIVERSITY OF BIRMINGHAM, European Commission, German Cancer Aid
Recurrent and refractory Ewing sarcoma, Ewing sarcoma, a type of bone cancer, that has either grown during initial treatment or has grown after the end of treatment., Diseases [C] - Cancer [C04]
 
 

Download Options